{"meta":{"query_hash":"7a3a24110d24","filters":{"venue":"Therapeutic Advances in Drug Safety"},"cohort_total":33,"direct_labels_cover":0,"predictions_cover":33,"exported":33,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7a3a24110d24","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Drug+Safety"},"results":[{"id":"W1951433376","doi":"10.1177/2042098615588084","title":"Risk of intracranial hypertension with intrauterine levonorgestrel","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Levonorgestrel; Gestodene; Odds ratio; Drospirenone; Confidence interval; Population; Obstetrics; Gynecology; Internal medicine; Family planning","score_opus":0.017540775232581175,"score_gpt":0.26960085121288196,"score_spread":0.2520600759803008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951433376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990166,0.0025833452,0.002837273,0.0007160411,0.00020805531,0.00045630807,0.000017535573,0.00007696203,0.0029384557],"genre_scores_gemma":[0.9881396,0.0039432566,0.0074602803,0.0002148393,0.000110508976,0.000008589388,0.000012622425,0.000038715134,0.00007153979],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985454,0.00010307189,0.0004213562,0.0002903968,0.0003431999,0.0002965866],"domain_scores_gemma":[0.9989639,0.00013114682,0.00018843295,0.0004247806,0.00015224339,0.00013951109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038179153,0.00021510581,0.0005837115,0.00011295439,0.000035322475,0.0000040083623,0.00013362525,0.00006569316,0.000050953655],"category_scores_gemma":[0.000058722268,0.0001545741,0.000055904893,0.0003559297,0.00024233467,0.00021703717,0.000047984373,0.00030227864,0.000015936868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01293104,0.0018826245,0.16887352,0.00026067698,0.00033357207,0.00019937224,0.003292664,0.0023586345,0.0029688494,0.0024261386,0.00005188336,0.804421],"study_design_scores_gemma":[0.034027893,0.0055803894,0.8490013,0.0014211982,0.0012201167,0.0014570578,0.0042222254,0.0060616434,0.010979297,0.020846523,0.06373388,0.0014484606],"about_ca_topic_score_codex":0.00032646142,"about_ca_topic_score_gemma":0.00044431537,"teacher_disagreement_score":0.80297256,"about_ca_system_score_codex":0.00015644301,"about_ca_system_score_gemma":0.00014611013,"threshold_uncertainty_score":0.63033485},"labels":[],"label_agreement":null},{"id":"W2044764653","doi":"10.1177/2042098613492366","title":"Selective serotonin reuptake inhibitors and <i>torsade de pointes</i> : new concepts and new directions derived from a systematic review of case reports","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Memorial University of Newfoundland","funders":"","keywords":"Citalopram; Medicine; QT interval; Sertraline; Fluoxetine; Serotonin reuptake inhibitor; Prolongation; Antidepressant; Food and drug administration; Long QT syndrome; Drug; Pharmacology; Culprit; Reuptake inhibitor; Intensive care medicine; Serotonin; Anesthesia; Psychiatry; Internal medicine","score_opus":0.01605437338666367,"score_gpt":0.32850619995567903,"score_spread":0.3124518265690154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044764653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032182544,0.99432516,0.00010062636,0.00013508856,0.00019885268,0.0046339957,0.000022339833,0.0000521516,0.00020996301],"genre_scores_gemma":[0.00047660572,0.99721324,0.0008459537,0.00038555134,0.00024656556,0.0002707537,0.000045134653,0.00006149583,0.0004546968],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99651086,0.00075598026,0.0015314056,0.0006544285,0.00017603072,0.0003712659],"domain_scores_gemma":[0.9968995,0.0010568507,0.0011167483,0.0005857647,0.00008552211,0.00025563658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049870723,0.00056191575,0.0041513583,0.00013928996,0.00008856848,0.000009799915,0.00006313842,0.00026179006,0.000041283663],"category_scores_gemma":[0.00036895782,0.00042090777,0.00038492013,0.00045679853,0.00023335112,0.00016518166,0.00007162559,0.00073846924,0.0000033442361],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087164066,0.00005248432,0.000020707266,0.6253498,0.0009847179,0.0016122905,0.0010049222,0.0000015650278,0.000042702817,0.000045304878,0.00020520664,0.37059313],"study_design_scores_gemma":[0.0007837988,0.00016923016,0.000030465088,0.8015297,0.006649849,0.037409045,0.00018085662,0.0000036863855,0.0000829617,0.0009658885,0.15163484,0.0005596497],"about_ca_topic_score_codex":0.0006013905,"about_ca_topic_score_gemma":0.00011107378,"teacher_disagreement_score":0.37003347,"about_ca_system_score_codex":0.0002516966,"about_ca_system_score_gemma":0.0007932148,"threshold_uncertainty_score":0.9998243},"labels":[],"label_agreement":null},{"id":"W2099543072","doi":"10.1177/2042098612451267","title":"Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Diabetes mellitus; Primary prevention; Intensive care medicine; Secondary prevention; Disease; Internal medicine; Endocrinology","score_opus":0.024539556583118998,"score_gpt":0.305003854526432,"score_spread":0.28046429794331296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099543072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031899798,0.98989105,0.00031492664,0.000026083508,0.00019104201,0.005989154,0.00027437223,0.000030256331,0.00009310367],"genre_scores_gemma":[0.032155395,0.96583533,0.0000518537,0.0001143527,0.00020864866,0.0010873285,0.00040196086,0.0001158714,0.000029249402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99628866,0.0008371925,0.0009128692,0.0005590142,0.0008033647,0.00059891545],"domain_scores_gemma":[0.997245,0.00059965043,0.00049019326,0.0014535427,0.000116731026,0.00009485711],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011906977,0.0006361488,0.0027552713,0.00016752849,0.00013377446,0.000017954433,0.00053169724,0.00019057728,0.000027256148],"category_scores_gemma":[0.000033894157,0.00031589082,0.0022654675,0.0006705211,0.00034144873,0.00032119866,0.00009791468,0.0004533887,0.000003665366],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041000303,0.00054319185,0.0044782683,0.009212321,0.0031474065,0.0000013068351,0.00015428741,0.00022880589,3.6417177e-8,0.00011977115,0.0000017653872,0.98170286],"study_design_scores_gemma":[0.004701894,0.00016433069,0.04851957,0.013210843,0.012269943,0.000005041846,0.00011397415,0.0000026190983,0.0000021894753,0.0002227632,0.9202852,0.00050163217],"about_ca_topic_score_codex":0.0000063703374,"about_ca_topic_score_gemma":0.0000086258915,"teacher_disagreement_score":0.98120123,"about_ca_system_score_codex":0.00022992196,"about_ca_system_score_gemma":0.00023468226,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W2159872359","doi":"10.1177/2042098613505614","title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pregabalin; Medicine; Neuropathic pain; Pain management; Intensive care medicine; Anesthesia","score_opus":0.11080718598801527,"score_gpt":0.44203784279271413,"score_spread":0.3312306568046989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159872359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013037297,0.97161084,0.022005767,0.0010037532,0.000164475,0.004959705,0.00005390486,0.000027887825,0.00017236019],"genre_scores_gemma":[0.00059695623,0.99401706,0.003839887,0.00022586803,0.00007059778,0.00075178186,0.000036095644,0.00005114011,0.0004105939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674046,0.0010691263,0.0012052963,0.00053181977,0.00016427528,0.0002890506],"domain_scores_gemma":[0.9900929,0.008365193,0.0005438277,0.0008423501,0.00007355509,0.00008219225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005206096,0.00037088562,0.001350331,0.00006633224,0.00012301965,0.000010735896,0.00033064903,0.00014165623,0.000015226323],"category_scores_gemma":[0.00018022602,0.0002145299,0.0003589686,0.00026310177,0.0002107713,0.000112147674,0.000118279044,0.00034692226,0.000007181039],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007227022,0.00017438622,0.00017600527,0.009000187,0.00042080742,0.0000031113877,0.000021848005,0.0000025427341,9.683115e-8,0.0060508694,0.00000674248,0.98407114],"study_design_scores_gemma":[0.00084336253,0.00019399865,0.0016820673,0.021314073,0.0027867144,0.000020954178,0.000039884708,0.00023631172,2.2918363e-7,0.0032591957,0.9694116,0.00021161739],"about_ca_topic_score_codex":0.000007943728,"about_ca_topic_score_gemma":0.000009181832,"teacher_disagreement_score":0.98385954,"about_ca_system_score_codex":0.000094576375,"about_ca_system_score_gemma":0.00009725024,"threshold_uncertainty_score":0.8748275},"labels":[],"label_agreement":null},{"id":"W2161475157","doi":"10.1177/2042098611424178","title":"Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Australia; Norwegian Institute of Public Health; Institute for Clinical Evaluative Sciences; U.S. Department of Veterans Affairs","keywords":"Pharmacoepidemiology; Medicine; Drug; Pharmacovigilance; Drug reaction; Pharmacology; Medical emergency; Intensive care medicine","score_opus":0.0853446839540162,"score_gpt":0.4357289746764908,"score_spread":0.35038429072247457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161475157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49467975,0.10457259,0.0038812356,0.056195956,0.028461311,0.005343803,0.0027422092,0.00090676034,0.30321637],"genre_scores_gemma":[0.86442506,0.12239517,0.00015070208,0.011367892,0.00064617576,0.00010666413,0.00007986281,0.00003585357,0.0007926126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959593,0.0016878505,0.00067831634,0.00056626875,0.0002597816,0.0008484719],"domain_scores_gemma":[0.9956764,0.0032865498,0.00036393825,0.00038805165,0.000051488678,0.00023357646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021712754,0.00047366688,0.00047024357,0.00011831942,0.0005414434,0.000022132295,0.0007030388,0.00015705163,0.0018184608],"category_scores_gemma":[0.00004065942,0.00035413427,0.00012647874,0.00025147494,0.0005231122,0.0004819486,0.00019735239,0.0015498842,0.0002266623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042320886,0.0013066754,0.2050713,0.000045835073,0.0014966447,0.000034977573,0.00632808,0.0075315293,0.0011692478,0.070484065,0.0025075807,0.69979197],"study_design_scores_gemma":[0.0034258417,0.000021743668,0.03875706,0.000057360194,0.00033424894,0.000014387638,0.0015720765,0.0053193527,0.00086995756,0.009172927,0.9399797,0.00047536564],"about_ca_topic_score_codex":0.000098484634,"about_ca_topic_score_gemma":0.000097818716,"teacher_disagreement_score":0.9374721,"about_ca_system_score_codex":0.00021675306,"about_ca_system_score_gemma":0.00003771881,"threshold_uncertainty_score":0.99989104},"labels":[],"label_agreement":null},{"id":"W2168494345","doi":"10.1177/2042098611429985","title":"Does orlistat cause acute kidney injury?","year":2011,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Clinical Evaluative Sciences","keywords":"Orlistat; Medicine; Acute kidney injury; Intensive care medicine; Weight loss; Internal medicine; Obesity","score_opus":0.0337585266041335,"score_gpt":0.3994630283586332,"score_spread":0.3657045017544997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168494345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066837256,0.9910098,0.000051390634,0.00022947066,0.0013211367,0.0015463843,0.0003742633,0.00012527757,0.005335651],"genre_scores_gemma":[0.000047614667,0.9901614,0.0003396854,0.0015078245,0.0002163365,0.00023080969,0.00032078076,0.00008526542,0.007090243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973729,0.00035978417,0.00082121976,0.0006685904,0.0001979922,0.00057949044],"domain_scores_gemma":[0.9983986,0.0001965081,0.00035478396,0.0007015247,0.00004625946,0.00030232777],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034216608,0.0007077793,0.002333261,0.00025756814,0.00011237751,0.0000075378816,0.00037109468,0.0003260485,0.0009982224],"category_scores_gemma":[0.000021501177,0.00037841662,0.00043597326,0.00036617773,0.00028983253,0.00021224402,0.0001213876,0.00090487,0.00032479427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054495124,0.00045837686,0.000075822514,0.0049339402,0.0013074226,0.00030438445,0.00028991772,8.3894335e-8,6.657665e-7,0.00081184297,0.00032837337,0.9909442],"study_design_scores_gemma":[0.0012067567,0.0001209995,0.00003328079,0.005270915,0.0054158657,0.00008720349,0.000014298486,7.036231e-7,0.00002049647,0.0010638975,0.98633856,0.00042700698],"about_ca_topic_score_codex":0.000017531926,"about_ca_topic_score_gemma":0.000022831326,"teacher_disagreement_score":0.9905172,"about_ca_system_score_codex":0.0005149814,"about_ca_system_score_gemma":0.0005679039,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W2475587874","doi":"10.1177/2042098616660947","title":"Citalopram and escitalopram: adverse cardiac outcomes in medically ill inpatients","year":2016,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Escitalopram; Medicine; Citalopram; Adverse effect; Intensive care medicine; Emergency medicine; Anesthesia; Internal medicine; Pharmacology; Antidepressant","score_opus":0.004056710642449825,"score_gpt":0.2849074620933553,"score_spread":0.2808507514509055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475587874","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062273804,0.03778826,0.00009832632,0.0015317744,0.8857829,0.0025174331,0.0007066253,0.0002104985,0.009090402],"genre_scores_gemma":[0.31539366,0.16417284,0.0006087173,0.0019149147,0.5081121,0.000502119,0.0012178046,0.00040550315,0.007672378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961869,0.0003480684,0.0009093014,0.0009128844,0.00085363304,0.0007892277],"domain_scores_gemma":[0.996591,0.002091854,0.00029691125,0.0006496395,0.00017367917,0.00019692488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007218208,0.00064850453,0.0019109645,0.00036058907,0.000082156395,0.000008034695,0.00023957297,0.00087557815,0.000063647516],"category_scores_gemma":[0.0008162588,0.00047297252,0.00030571056,0.0003094372,0.0006113742,0.0003122011,0.00017991771,0.0016302236,0.00004451057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016685754,0.0014267454,0.05814131,0.0018587521,0.0022683043,0.0023551944,0.0036067115,0.000080121165,0.0004447582,0.0014446053,0.08466691,0.8270208],"study_design_scores_gemma":[0.0056520677,0.0003331212,0.02103873,0.0010038015,0.00019081015,0.000010979368,0.00013531545,0.0000054117063,0.00002028685,0.002929997,0.9679842,0.00069530605],"about_ca_topic_score_codex":0.00004235817,"about_ca_topic_score_gemma":0.00010599927,"teacher_disagreement_score":0.8833173,"about_ca_system_score_codex":0.00043751052,"about_ca_system_score_gemma":0.00045121674,"threshold_uncertainty_score":0.9997722},"labels":[],"label_agreement":null},{"id":"W2534941481","doi":"10.1177/2042098616673990","title":"Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Apixaban; Stroke (engine); Warfarin; Intensive care medicine; Clinical trial; Guideline; Clinical Practice; Randomized controlled trial; Internal medicine; Physical therapy","score_opus":0.1279470371399663,"score_gpt":0.42488757964953555,"score_spread":0.29694054250956925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534941481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001837041,0.99115944,0.0013111044,0.0012374648,0.0006925996,0.0051210765,0.000047624708,0.00002219427,0.00022481293],"genre_scores_gemma":[0.0042805416,0.99315464,0.0004014876,0.000025823228,0.0010549695,0.000011677661,0.000027255663,0.000039090657,0.0010044941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968658,0.00062429963,0.0013740779,0.00043527997,0.00039871107,0.00030184104],"domain_scores_gemma":[0.99532,0.0031402456,0.0008404512,0.0005911467,0.00006115806,0.000046948087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016173196,0.0003652711,0.0016824804,0.00016001718,0.00012786848,0.000016670363,0.00029897148,0.00016033158,0.00005923941],"category_scores_gemma":[0.00030210672,0.00018209906,0.00059678307,0.00045328925,0.00023208524,0.00024895096,0.0001379426,0.00021472022,0.0000057460516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020383704,0.0000057823418,0.0036217622,0.0024746624,0.00016657119,5.6018524e-7,0.00011914919,0.00010883965,0.000001241612,0.0032570355,0.000014904152,0.9881911],"study_design_scores_gemma":[0.0033010724,0.000059719354,0.009475091,0.013014455,0.0004909339,0.0000031786112,0.000049236787,0.000047360973,0.0000015453877,0.0008462815,0.97249514,0.00021598383],"about_ca_topic_score_codex":0.000008152089,"about_ca_topic_score_gemma":0.00002175763,"teacher_disagreement_score":0.9879751,"about_ca_system_score_codex":0.00016849465,"about_ca_system_score_gemma":0.0002167893,"threshold_uncertainty_score":0.7425784},"labels":[],"label_agreement":null},{"id":"W2586356521","doi":"10.1177/2042098616689771","title":"Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Concomitant; Apixaban; Medicine; Adverse effect; Odds ratio; Adverse drug reaction; Internal medicine; Emergency medicine; Drug; Warfarin; Pharmacology","score_opus":0.031873528298698946,"score_gpt":0.3541906558766836,"score_spread":0.32231712757798464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586356521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539311,0.014480895,0.0005538344,0.007563565,0.0011010901,0.0010776133,0.00000513475,0.000060290164,0.021226497],"genre_scores_gemma":[0.9935502,0.003794078,0.000502869,0.00020088206,0.00018832767,0.000001796999,0.0000059687236,0.000015005454,0.0017409187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987823,0.00004069224,0.00052071793,0.00023352416,0.00025026413,0.00017254299],"domain_scores_gemma":[0.99875194,0.00018340287,0.00043174357,0.0005265113,0.0000477018,0.000058699246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049506157,0.00014870088,0.00049636915,0.000082211394,0.00011516295,0.0000072393586,0.0001041029,0.000042739397,0.00007616443],"category_scores_gemma":[0.00017564054,0.000113208785,0.00006672854,0.00005643263,0.00020882007,0.0002087983,0.000076653254,0.00009446538,0.0000025760944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015448692,0.000026632106,0.7697594,0.00029842465,0.00010868251,0.0014941513,0.0006873946,0.000052605134,0.0005236648,0.002710089,0.00002324283,0.22277081],"study_design_scores_gemma":[0.004546477,0.00018432247,0.8753074,0.0005102418,0.00026488185,0.0012725961,0.0006454123,0.00042119672,0.00054805883,0.017059084,0.098926775,0.00031356208],"about_ca_topic_score_codex":0.000035048946,"about_ca_topic_score_gemma":0.00008928812,"teacher_disagreement_score":0.22245724,"about_ca_system_score_codex":0.000037888763,"about_ca_system_score_gemma":0.000030632138,"threshold_uncertainty_score":0.46165204},"labels":[],"label_agreement":null},{"id":"W2610100066","doi":"10.1177/2042098617702615","title":"Risk factors for adverse drug reactions in pediatric inpatients: a systematic review","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Provincial Health Services Authority; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Observational study; MEDLINE; Medical prescription; Cohort study; Data extraction; Population; Risk factor; Pharmacoepidemiology; Incidence (geometry); Systematic review; Epidemiology; Cohort; Prospective cohort study; Pediatrics; Internal medicine; Environmental health; Pharmacology","score_opus":0.10653980338035274,"score_gpt":0.45913101452308125,"score_spread":0.3525912111427285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610100066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000432235,0.9871849,0.00004820904,0.00018275186,0.00067955867,0.009637686,0.00018422019,0.00005024602,0.0020281305],"genre_scores_gemma":[0.00010720688,0.99692166,0.00012399077,0.00024865914,0.00018934313,0.0015275357,0.000106568674,0.00007982199,0.0006952446],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951344,0.0009197072,0.0022442786,0.0006786356,0.00042362628,0.00059934997],"domain_scores_gemma":[0.9912055,0.004994796,0.0025448927,0.0009828627,0.000105894076,0.00016605726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023053086,0.0007145665,0.004782321,0.00030154453,0.0002918051,0.000017300958,0.00053304207,0.00017592782,0.000058211222],"category_scores_gemma":[0.002603044,0.00047573828,0.00081147195,0.000565694,0.00011417445,0.00051415747,0.00013062032,0.001226589,0.000049698705],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081973405,0.0002265606,0.00017818421,0.7878053,0.00024330664,0.000009650675,0.00017650117,0.0000023738862,2.3949474e-9,0.00005333998,0.000037792368,0.211185],"study_design_scores_gemma":[0.0007443222,0.0000386069,0.000040407944,0.26942995,0.007941525,0.000010163194,0.00012411221,0.000009431141,3.3027668e-8,0.00012174174,0.72119796,0.00034173374],"about_ca_topic_score_codex":0.00008218131,"about_ca_topic_score_gemma":0.00015646043,"teacher_disagreement_score":0.7211602,"about_ca_system_score_codex":0.0005767877,"about_ca_system_score_gemma":0.00022889192,"threshold_uncertainty_score":0.99976945},"labels":[],"label_agreement":null},{"id":"W2705232493","doi":"10.1177/2042098617709768","title":"Revised disproportionality analysis of Mirena and benign intracranial hypertension","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.0213415122708033,"score_gpt":0.3203688792583498,"score_spread":0.2990273669875465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2705232493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922506,0.0037099167,0.00048798154,0.0014577897,0.0000996771,0.00035312615,0.000028298651,0.00002478289,0.001587818],"genre_scores_gemma":[0.9948923,0.0033915353,0.0013455654,0.00019885342,0.000050229966,0.0000059521967,0.000027011838,0.000014645967,0.0000739183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986102,0.000073004776,0.00049092754,0.0003275373,0.0002930666,0.00020529177],"domain_scores_gemma":[0.9986503,0.00013296002,0.0003347005,0.00070149545,0.000103985316,0.00007654891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050337805,0.0001598473,0.0007728986,0.00014935783,0.00018054429,0.000012355547,0.00015993066,0.000062916224,0.00015471116],"category_scores_gemma":[0.00012231039,0.00012808462,0.00014321356,0.0002387459,0.00041329098,0.00024559945,0.00007424387,0.00015789075,0.0000022616023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022361402,0.00082129374,0.50315946,0.0003318798,0.0014105194,0.00004645524,0.00079771003,0.000104669074,0.007519862,0.0048019346,0.000010416173,0.47875968],"study_design_scores_gemma":[0.0014212274,0.000072343566,0.99129677,0.00013144375,0.0014605363,0.00001357649,0.00009823326,0.0016200661,0.000392676,0.0018098055,0.0015398505,0.00014350192],"about_ca_topic_score_codex":0.00027914054,"about_ca_topic_score_gemma":0.00061380566,"teacher_disagreement_score":0.4881373,"about_ca_system_score_codex":0.000065877524,"about_ca_system_score_gemma":0.00004595769,"threshold_uncertainty_score":0.52231395},"labels":[],"label_agreement":null},{"id":"W2786833446","doi":"10.1177/2042098617751498","title":"Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lactose intolerance; Medicine; Codeine; Lactose; Population; Intensive care medicine; Adverse effect; Excipient; Pharmacy; Anesthesia; Morphine; Pharmacology; Food science; Environmental health","score_opus":0.013765477836603781,"score_gpt":0.32945774833548575,"score_spread":0.315692270498882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786833446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010595284,0.9924847,0.00045958956,0.00005522451,0.0006015217,0.0017790807,0.00006414327,0.00001519965,0.003481014],"genre_scores_gemma":[0.005174057,0.9927919,0.000109722714,0.00016132496,0.00018064985,0.00008923303,0.0005713861,0.00007554117,0.00084622257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951266,0.001445162,0.001732997,0.0008405002,0.00032850847,0.0005262511],"domain_scores_gemma":[0.9973201,0.00013829475,0.0011243313,0.0012042542,0.0001242258,0.000088781664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031733813,0.0005417829,0.0013835749,0.00015829325,0.000110019704,0.00000967775,0.0007158399,0.00040737775,0.000012289198],"category_scores_gemma":[0.0000741814,0.00035893868,0.0002543234,0.00046169825,0.00028472734,0.000023331584,0.0001883514,0.000475585,0.000004388842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004198738,0.00021661355,0.00046096186,0.0029675416,0.00019659063,0.000023942643,0.00035937797,0.00006377774,0.0000020721748,0.00008985469,0.000031842457,0.99516755],"study_design_scores_gemma":[0.0009308272,0.0003912007,0.0012636535,0.008017946,0.00014168464,0.000016981967,0.00012601202,0.000027261953,0.000013589351,0.00016834386,0.98844904,0.00045347202],"about_ca_topic_score_codex":0.000046145702,"about_ca_topic_score_gemma":0.00020525914,"teacher_disagreement_score":0.9947141,"about_ca_system_score_codex":0.00017939694,"about_ca_system_score_gemma":0.00023517347,"threshold_uncertainty_score":0.9998863},"labels":[],"label_agreement":null},{"id":"W2829531973","doi":"10.1177/2042098618795770","title":"Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Deprescribing; Nice; Context (archaeology); Polypharmacy; Guideline; Excellence; Pharmacist; Medication therapy management; Regimen; Family medicine; Multimorbidity; Intensive care medicine; Pharmacy; Chronic disease; Internal medicine","score_opus":0.10680681770426757,"score_gpt":0.45466308968180696,"score_spread":0.3478562719775394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2829531973","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10695291,0.07534383,0.47886372,0.31539062,0.0020598292,0.015891988,0.00022010518,0.00046879076,0.004808216],"genre_scores_gemma":[0.9418717,0.012615552,0.030815883,0.01270832,0.0010320225,0.0007328404,0.0000472276,0.00005262066,0.0001238454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984327,0.00008453481,0.0005707027,0.00044729156,0.00015288858,0.0003119148],"domain_scores_gemma":[0.99593425,0.0023403084,0.0003219793,0.00051903713,0.0007961305,0.00008832339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011615246,0.00019381035,0.0003389059,0.000040846528,0.00034857352,0.00007648162,0.00018217803,0.000047514386,0.000011026807],"category_scores_gemma":[0.0017761743,0.00012449223,0.000077688084,0.00018213394,0.0003511302,0.00085426535,0.00007619502,0.00013396856,0.0000017055195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037660582,0.00054228684,0.03405917,0.0006410225,0.0003834356,0.0000019232862,0.0019884123,0.0003193861,0.000010699406,0.011030077,0.0020101368,0.9452474],"study_design_scores_gemma":[0.009766921,0.0003517895,0.22915775,0.00096239505,0.0010353591,0.000025310583,0.0653537,0.007950081,0.000030177624,0.0063339076,0.6785372,0.00049541],"about_ca_topic_score_codex":0.000019797257,"about_ca_topic_score_gemma":0.0003925474,"teacher_disagreement_score":0.944752,"about_ca_system_score_codex":0.000052405878,"about_ca_system_score_gemma":0.00014495189,"threshold_uncertainty_score":0.50766456},"labels":[],"label_agreement":null},{"id":"W2891540702","doi":"10.1177/2042098618794165","title":"Strategies to promote public engagement around deprescribing","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Vancouver Coastal Health; Canadian Patient Safety Institute; University of British Columbia; Institut Universitaire de Gériatrie de Montréal","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Deprescribing; Polypharmacy; Medicine; Enabling; Public relations; Nursing; Psychiatry; Political science","score_opus":0.25095876490454566,"score_gpt":0.4807666275083062,"score_spread":0.22980786260376052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891540702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021072594,0.9715634,0.001480128,0.0005641227,0.000791629,0.0030429724,0.000022021712,0.00011623474,0.022398418],"genre_scores_gemma":[0.0010559222,0.9949283,0.0017137048,0.00092269847,0.00042838728,0.00020258501,0.00006923817,0.00009355599,0.000585629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962007,0.0006064071,0.0011143138,0.0007707816,0.00055156334,0.00075626705],"domain_scores_gemma":[0.99769545,0.0007494137,0.00039933415,0.00076488446,0.00008737955,0.00030354763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014704688,0.00063618185,0.0018098716,0.00033738263,0.00016594968,0.00011199778,0.0004955706,0.00017814571,0.00028952272],"category_scores_gemma":[0.00015190356,0.0004648951,0.00035435962,0.00074427924,0.0001473967,0.00083454826,0.00025302664,0.0011304113,0.0003055842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014274,0.00020057478,0.000047446483,0.007688135,0.00022956361,0.000029233224,0.00035508064,0.000005867971,4.385533e-7,0.0021936938,0.00003554435,0.98907167],"study_design_scores_gemma":[0.0006515596,0.00016218779,0.000011873228,0.0073546222,0.00071359624,0.000035395857,0.00039886794,0.000056770616,0.000001529336,0.0007753435,0.989369,0.00046925136],"about_ca_topic_score_codex":0.000010127703,"about_ca_topic_score_gemma":0.000040147435,"teacher_disagreement_score":0.98933345,"about_ca_system_score_codex":0.00044299982,"about_ca_system_score_gemma":0.00046992203,"threshold_uncertainty_score":0.9997803},"labels":[],"label_agreement":null},{"id":"W2897929033","doi":"10.1177/2042098618804490","title":"Deprescribing conversations: a closer look at prescriber–patient communication","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa; University of Waterloo; Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Deprescribing; Medicine; Conversation; Thematic analysis; Health care; Action (physics); Family medicine; Nursing; Qualitative research; Psychology; Polypharmacy; Internal medicine; Communication","score_opus":0.0979747242222918,"score_gpt":0.3990011828173144,"score_spread":0.3010264585950226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897929033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41134948,0.23192143,0.0055905147,0.028450022,0.006360808,0.017809879,0.00030287224,0.0018424412,0.29637256],"genre_scores_gemma":[0.984631,0.0051750625,0.0039885007,0.0042548217,0.00012171125,0.00071259,0.00010382635,0.000058275462,0.00095418235],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429375,0.0027951465,0.0013100335,0.00047376732,0.0004102668,0.00071705785],"domain_scores_gemma":[0.9944202,0.0021184452,0.0006508176,0.0021883694,0.0004795039,0.00014267277],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006377779,0.0002792475,0.00037295333,0.0001849369,0.0018535574,0.000009888631,0.00089869095,0.00018521179,0.0008061655],"category_scores_gemma":[0.00026607933,0.0002744049,0.00006987996,0.0004853005,0.0005131433,0.0007427352,0.00080149795,0.00085231726,0.00065761385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039072684,0.000675445,0.24308623,0.00090679555,0.0001568743,0.0000043822088,0.43434978,0.00069073436,0.00055105716,0.070626654,0.0037229739,0.24132182],"study_design_scores_gemma":[0.0038335419,0.00019081218,0.01738411,0.0015138073,0.000047789767,0.0000043906034,0.05298017,0.003687751,0.000628906,0.030083299,0.8888787,0.0007666945],"about_ca_topic_score_codex":0.0006431329,"about_ca_topic_score_gemma":0.0055280393,"teacher_disagreement_score":0.88515574,"about_ca_system_score_codex":0.001324704,"about_ca_system_score_gemma":0.0002730551,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W2910310106","doi":"10.1177/2042098618816562","title":"The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Sleep and related disorders","field":"Psychology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Deprescribing; Intervention (counseling); Population; Interquartile range; Family medicine; Psychiatry; Polypharmacy; Internal medicine","score_opus":0.009310330328651025,"score_gpt":0.3451581186524846,"score_spread":0.33584778832383355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910310106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139184,0.0046853432,0.00006234604,0.00016211446,0.00068778795,0.0020947591,0.000006973371,0.00001623243,0.0008926328],"genre_scores_gemma":[0.9993749,0.0003598855,0.000008346995,0.000031043553,0.000008764553,0.000116967894,0.000008345906,0.000015636382,0.00007608252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984389,0.00038163888,0.00045647903,0.000370933,0.00012482707,0.00022720052],"domain_scores_gemma":[0.9990854,0.0002441955,0.00016763389,0.00040605784,0.000061141734,0.000035515775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044719866,0.00018157018,0.00024319853,0.00015699347,0.00005003601,0.00001509687,0.00017418394,0.000063771506,0.00007715703],"category_scores_gemma":[0.000035356934,0.00011512286,0.000104465435,0.00026198628,0.00006259991,0.00017690755,0.000053247397,0.00020651697,0.000014034348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000901667,0.0036209873,0.72757334,0.000013750538,0.00010015507,2.12887e-7,0.023481334,0.00028701298,0.000012817978,0.00019087117,0.0000045184697,0.24381337],"study_design_scores_gemma":[0.001729559,0.0012288376,0.93941665,0.00014504159,0.000015088398,7.663141e-7,0.055931907,0.000054508833,0.000014370604,0.0012925818,0.000041588122,0.00012912134],"about_ca_topic_score_codex":0.0017334212,"about_ca_topic_score_gemma":0.0052655223,"teacher_disagreement_score":0.24368423,"about_ca_system_score_codex":0.0001335398,"about_ca_system_score_gemma":0.00002101661,"threshold_uncertainty_score":0.4694574},"labels":[],"label_agreement":null},{"id":"W2929153482","doi":"10.1177/2042098619838796","title":"‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Focus group; Thematic analysis; Conceptualization; Qualitative research; Medicine; Health care; Patient safety; Coding (social sciences); Nursing; Family medicine; Psychology; Sociology","score_opus":0.04686869312813717,"score_gpt":0.4009324925274406,"score_spread":0.35406379939930344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929153482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5142763,0.24823189,0.011367314,0.08554435,0.0048727132,0.021976933,0.0004383912,0.0009025555,0.11238956],"genre_scores_gemma":[0.95359427,0.02131892,0.015936252,0.008463082,0.000089634916,0.00025219208,0.000025691053,0.000058047823,0.00026191128],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99553585,0.0011604702,0.0012715602,0.00079118466,0.0006448184,0.0005961048],"domain_scores_gemma":[0.9885673,0.00902268,0.00050817576,0.001295556,0.00033888634,0.00026739828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008907452,0.00036981807,0.0006831597,0.00034490397,0.00090215873,0.0000114087525,0.0005743532,0.00019054025,0.0009090136],"category_scores_gemma":[0.00095131993,0.0002948786,0.00004432391,0.0005350329,0.00028436555,0.00043377868,0.00046978967,0.0010234278,0.00011452073],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036842714,0.0001861236,0.0061883065,0.0002601912,0.00008758217,0.0000023943335,0.7068402,0.0010908496,0.00006131474,0.019245418,0.00043721366,0.2619161],"study_design_scores_gemma":[0.008609086,0.0010288552,0.09292409,0.009726322,0.000084592444,0.0000067067404,0.7299813,0.0043133767,0.0000037868958,0.02105737,0.13118245,0.0010820816],"about_ca_topic_score_codex":0.00013042848,"about_ca_topic_score_gemma":0.00020723048,"teacher_disagreement_score":0.43931797,"about_ca_system_score_codex":0.00059602165,"about_ca_system_score_gemma":0.0002773374,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W2933544291","doi":"10.1177/2042098619836032","title":"Abuse potential of mirogabalin in recreational polydrug users","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Company","keywords":"Pregabalin; Medicine; Placebo; Crossover study; Pharmacology; Drug; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.00677971735060432,"score_gpt":0.27957617686638103,"score_spread":0.2727964595157767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933544291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896915,0.0041106096,0.00054856046,0.00025036567,0.00023827789,0.00060947315,0.000016040136,0.000024069708,0.004511092],"genre_scores_gemma":[0.9931541,0.0029853396,0.0026480476,0.00023832302,0.000025603813,0.000014264068,0.00003460085,0.000018206036,0.0008814851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882966,0.00008618689,0.00036190468,0.00023939415,0.00025774888,0.0002250752],"domain_scores_gemma":[0.9994583,0.00010641654,0.00010276237,0.00025533995,0.000030182715,0.00004696181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000293981,0.00014593652,0.0003428649,0.00015082685,0.000016750482,0.0000024507417,0.00009593888,0.000056822184,0.00026838988],"category_scores_gemma":[0.000008549755,0.00012350404,0.00007353095,0.00023621994,0.00005022407,0.00016263261,0.000016114902,0.00014281788,0.000037482198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011991333,0.0038287828,0.60353726,0.00055545993,0.00047003492,0.00025152884,0.0077299774,0.00873197,0.039528895,0.0374489,0.000013652938,0.2859122],"study_design_scores_gemma":[0.040968135,0.00086112635,0.8650346,0.002360574,0.00025538245,0.0000827168,0.004627812,0.0069067255,0.020412864,0.025978675,0.031530302,0.0009810978],"about_ca_topic_score_codex":0.00008778622,"about_ca_topic_score_gemma":0.00009568527,"teacher_disagreement_score":0.2849311,"about_ca_system_score_codex":0.00012994827,"about_ca_system_score_gemma":0.0000614617,"threshold_uncertainty_score":0.50363487},"labels":[],"label_agreement":null},{"id":"W2964635562","doi":"10.1177/2042098619865413","title":"Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada; British Medical Association; Biocon","keywords":"Postmarketing surveillance; Medicine; Context (archaeology); Pharmacovigilance; Population; Medical prescription; Adverse effect; Business; Family medicine; Environmental health; Pharmacology","score_opus":0.07323397650846275,"score_gpt":0.38139088917345754,"score_spread":0.3081569126649948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964635562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030032996,0.9867496,0.0000010998141,0.005325176,0.0002578294,0.003006595,0.000030189063,0.00000526728,0.0043239044],"genre_scores_gemma":[0.057818186,0.9341581,9.834787e-7,0.007821245,0.000047653062,0.00010021911,0.0000069145767,0.000019507403,0.000027177113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958901,0.002585516,0.00049637887,0.00032292074,0.0004588944,0.00024623433],"domain_scores_gemma":[0.9860536,0.012982211,0.00043887817,0.00042957836,0.00006152638,0.00003424897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027699133,0.00034880868,0.00128334,0.00005394542,0.00016618475,0.000012241258,0.00024880742,0.0000656074,0.000019037856],"category_scores_gemma":[0.0008304877,0.00013748262,0.000110856956,0.00054564,0.0002288827,0.00004549,0.00008021845,0.001065792,0.0000010886606],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049055356,0.00004660982,0.0004582049,0.011214527,0.00023883408,0.000006386596,0.00022700362,0.0000032046892,1.29176e-7,0.0019143595,0.00012504467,0.98527515],"study_design_scores_gemma":[0.00057754957,0.00010517078,0.0027890874,0.032185618,0.00043804946,0.000028113707,0.00029489564,0.00000778069,5.52341e-7,0.0000691931,0.9633589,0.00014512436],"about_ca_topic_score_codex":0.019968728,"about_ca_topic_score_gemma":0.081979714,"teacher_disagreement_score":0.98513,"about_ca_system_score_codex":0.00020733102,"about_ca_system_score_gemma":0.00021422112,"threshold_uncertainty_score":0.98655736},"labels":[],"label_agreement":null},{"id":"W2981890157","doi":"10.1177/2042098619883156","title":"Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use","year":2019,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Polypharmacy; Deprescribing; Medicine; Medical emergency; Beers Criteria; Intensive care medicine","score_opus":0.06828952103001117,"score_gpt":0.3856460790282565,"score_spread":0.3173565579982453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981890157","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04187628,0.20490743,0.00095754245,0.058477875,0.6724774,0.015537024,0.00033398945,0.00012082691,0.0053116223],"genre_scores_gemma":[0.58824605,0.07205805,0.00037413984,0.005308413,0.3325157,0.00038271747,0.00011601922,0.00016334276,0.0008355899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968431,0.00058045867,0.0008875537,0.0004526902,0.0008102639,0.0004259214],"domain_scores_gemma":[0.99056274,0.008028846,0.0005866637,0.00063263753,0.00010754992,0.00008159228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023226303,0.00033619217,0.0006292169,0.0001572891,0.00029475577,0.000041801643,0.00054791354,0.00021467924,0.00005151966],"category_scores_gemma":[0.0012162183,0.00017277147,0.00016136417,0.0006857582,0.00026654836,0.00043985824,0.00025386657,0.0017451243,0.00000863847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03155359,0.0008329538,0.15533884,0.0015743141,0.0015501811,0.000019432122,0.032524865,0.0043110466,0.00018798916,0.0019702946,0.14166467,0.6284718],"study_design_scores_gemma":[0.00204517,0.000072780975,0.003077119,0.0005053048,0.00034179105,0.000008798696,0.00088134926,0.003273271,0.00009521542,0.0009109804,0.98859155,0.0001966864],"about_ca_topic_score_codex":0.00047743393,"about_ca_topic_score_gemma":0.0017380005,"teacher_disagreement_score":0.84692687,"about_ca_system_score_codex":0.00026861703,"about_ca_system_score_gemma":0.0003013339,"threshold_uncertainty_score":0.75817937},"labels":[],"label_agreement":null},{"id":"W3095340726","doi":"10.1177/2042098620968310","title":"Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute on Aging","keywords":"Polypharmacy; Medicine; Medical prescription; Disease; Family medicine; Nursing; Pharmacology","score_opus":0.09343555958131636,"score_gpt":0.463842611985989,"score_spread":0.37040705240467264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095340726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905215,0.0026805394,0.00014829844,0.0036048368,0.0000949985,0.0023168453,0.00009276793,0.000011458117,0.00052877766],"genre_scores_gemma":[0.9981147,0.00018750252,0.00066246523,0.00063206395,0.00002298707,0.00028090793,0.00008641515,0.000008896209,0.0000040501127],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99553263,0.0025651979,0.0010310375,0.0002565356,0.0003533355,0.0002612668],"domain_scores_gemma":[0.99827224,0.00084900105,0.0004511602,0.00013232895,0.0002012871,0.000093985494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031984914,0.00013176045,0.00026892062,0.00012209418,0.00013975425,0.000008008734,0.00010453597,0.000043325417,0.0001775871],"category_scores_gemma":[0.0004690995,0.000108596876,0.000013058304,0.00029213482,0.000103814644,0.0014648563,0.00004877296,0.00032479508,0.000001675614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012776164,0.00010519512,0.35303116,0.0009151412,0.000011780472,2.1120388e-7,0.6237404,0.0009019563,0.0000133046,0.0015755019,0.00000902212,0.018418709],"study_design_scores_gemma":[0.0042083086,0.00005107298,0.77238774,0.0012538387,0.00003633562,9.1560025e-8,0.21319649,0.0049603293,0.00004962351,0.0020873523,0.0015449487,0.00022386451],"about_ca_topic_score_codex":0.0004342973,"about_ca_topic_score_gemma":0.00066175516,"teacher_disagreement_score":0.41935658,"about_ca_system_score_codex":0.00029146223,"about_ca_system_score_gemma":0.0007491083,"threshold_uncertainty_score":0.44284523},"labels":[],"label_agreement":null},{"id":"W3125106283","doi":"10.1177/2042098621989134","title":"Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Adverse effect; Systematic review; Transporter; Pharmacology; MEDLINE; Intensive care medicine; Bioinformatics; Biochemistry","score_opus":0.09842730358675036,"score_gpt":0.40746611403547806,"score_spread":0.3090388104487277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125106283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004751908,0.991724,0.000070673595,0.000015648498,0.00019624946,0.0069852555,0.00007498267,0.00004966529,0.00083596655],"genre_scores_gemma":[0.00021334986,0.9965862,0.0004913286,0.00012101258,0.000036988098,0.00068960816,0.0011487831,0.00009802856,0.00061471865],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947991,0.0013815855,0.0021332293,0.0006587557,0.0005854657,0.0004418974],"domain_scores_gemma":[0.9965753,0.00056410284,0.0017127356,0.0008922829,0.00013243845,0.00012316515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015425906,0.00079104217,0.006223913,0.00027259483,0.00004782952,0.0000057561033,0.00028252506,0.00017350959,0.00010998079],"category_scores_gemma":[0.00008350394,0.000500944,0.00073064736,0.00082306174,0.00012780033,0.00036253413,0.0000385592,0.00036184434,0.000034168537],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015264463,0.0017347512,0.00016716293,0.5739786,0.002748599,0.00012379301,0.0008455578,0.000005139746,4.1764375e-7,0.0012425564,0.000015608075,0.41898516],"study_design_scores_gemma":[0.0016584658,0.00038276517,0.000051242587,0.48850456,0.0075022727,0.0000057305797,0.00034231012,0.000004895103,0.0000034470258,0.000059652124,0.50105095,0.00043375173],"about_ca_topic_score_codex":0.000008228258,"about_ca_topic_score_gemma":0.00011595913,"teacher_disagreement_score":0.50103533,"about_ca_system_score_codex":0.00046825525,"about_ca_system_score_gemma":0.00024866103,"threshold_uncertainty_score":0.99974424},"labels":[],"label_agreement":null},{"id":"W3160853723","doi":"10.1177/20420986211011345","title":"Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Internal medicine; Intensive care unit; Confidence interval; Intensive care medicine","score_opus":0.14488365894393107,"score_gpt":0.4613328342968165,"score_spread":0.3164491753528854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160853723","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.383056e-7,0.98031825,0.002263857,0.011634898,0.00006548183,0.0054343063,0.0001943861,0.00006998439,0.000018008948],"genre_scores_gemma":[0.00032100463,0.9940071,0.00094197295,0.0030188523,0.000026070673,0.0009976163,0.0001710349,0.00007060872,0.00044570584],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99079335,0.002729642,0.0034496624,0.0015617581,0.0008624273,0.0006031608],"domain_scores_gemma":[0.9698305,0.026797256,0.001058738,0.0017007618,0.00019405117,0.0004186805],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0037108723,0.00094678905,0.017978474,0.0009069794,0.0001800278,0.00006851353,0.00041106014,0.0003134531,0.00009178426],"category_scores_gemma":[0.00770877,0.00062055414,0.0020143325,0.0029046757,0.00038394297,0.00020397789,0.0004375178,0.0010496146,0.000011701488],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055128778,0.00014728571,0.00024984858,0.8849257,0.101716906,0.0003530224,0.0006656859,0.000012637657,3.0114506e-8,0.0006296216,0.00007219234,0.011171933],"study_design_scores_gemma":[0.0010845064,0.00004278793,0.00010780898,0.13155633,0.5791391,0.00003478012,0.00024876033,0.000040998846,1.7395829e-8,0.00012860555,0.28700665,0.0006096589],"about_ca_topic_score_codex":0.00027410412,"about_ca_topic_score_gemma":0.00039008228,"teacher_disagreement_score":0.7533694,"about_ca_system_score_codex":0.0013156331,"about_ca_system_score_gemma":0.0005574203,"threshold_uncertainty_score":0.99962455},"labels":[],"label_agreement":null},{"id":"W4248034719","doi":"10.1177/2042098615621264","title":"Risk of intracranial hypertension with intrauterine levonorgestrel: reply","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Levonorgestrel; Internal medicine; Family planning; Population; Environmental health","score_opus":0.01766261295001534,"score_gpt":0.27077415597657317,"score_spread":0.2531115430265578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248034719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902945,0.0026451284,0.001785823,0.0012415204,0.00023555101,0.0005217982,0.000017754328,0.00010721285,0.0031506699],"genre_scores_gemma":[0.987118,0.004032013,0.008081843,0.00048659093,0.00012638485,0.000009992676,0.000013811315,0.00004780673,0.00008354993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833417,0.00012295671,0.0004981223,0.00034926512,0.00037612565,0.00031933724],"domain_scores_gemma":[0.99873483,0.00015242121,0.00023450085,0.0005502786,0.00017809565,0.00014984938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004891318,0.00023351304,0.0006369516,0.000121133045,0.00003976086,0.0000047174735,0.00014686966,0.000060667728,0.000058396803],"category_scores_gemma":[0.000089820074,0.00016935854,0.00006303334,0.0003954684,0.0002599973,0.00023822433,0.000053946453,0.00033279805,0.000015623493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016778637,0.0019559318,0.17500101,0.00029882495,0.00039491287,0.00028010964,0.003859254,0.002234901,0.0028055331,0.0016123535,0.00013247022,0.7946461],"study_design_scores_gemma":[0.035026968,0.0069352016,0.7726827,0.0017283835,0.0013808407,0.0019807972,0.004538768,0.0052877693,0.012746471,0.014847345,0.1411888,0.0016559483],"about_ca_topic_score_codex":0.0004715573,"about_ca_topic_score_gemma":0.0003998362,"teacher_disagreement_score":0.7929901,"about_ca_system_score_codex":0.00017507345,"about_ca_system_score_gemma":0.00016234755,"threshold_uncertainty_score":0.69062406},"labels":[],"label_agreement":null},{"id":"W4306669620","doi":"10.1177/20420986221129335","title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Medicine; Meta-analysis; Hazard ratio; Angiotensin Receptor Blockers; Observational study; Internal medicine; MEDLINE; Oncology; Cohort study; Relative risk; Angiotensin-converting enzyme; Publication bias; Confidence interval; Pharmacology; Blood pressure","score_opus":0.10505555536227236,"score_gpt":0.37435989132604996,"score_spread":0.2693043359637776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306669620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7931328,0.19558924,0.00007467688,0.009059853,0.0005187233,0.001062445,0.00040427185,0.00011563015,0.00004240184],"genre_scores_gemma":[0.9870441,0.0060618646,0.0047292025,0.0010531408,0.00011763678,0.000105012754,0.00013565017,0.000057827758,0.0006955442],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959522,0.0007524024,0.0012785639,0.0007558637,0.0008050851,0.00045590804],"domain_scores_gemma":[0.99725616,0.00069484836,0.0008531991,0.00057421403,0.00051511335,0.00010647158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015713859,0.00044487815,0.0025710901,0.0005877701,0.00040906368,0.000010071425,0.00018270138,0.000071356895,0.00052251626],"category_scores_gemma":[0.00015489571,0.00032555385,0.00064747175,0.0024529088,0.0004218635,0.00029825832,0.0002538562,0.00038585716,0.0000015304109],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008340408,0.000809795,0.43926632,0.00012475546,0.42853284,0.00011879684,0.03644348,0.040650774,0.0063915728,0.000378119,0.0045088492,0.03443429],"study_design_scores_gemma":[0.008188505,0.0012747424,0.33580795,0.00017952661,0.3985829,0.00010371867,0.027108444,0.016484812,0.008487092,0.0005841435,0.2009491,0.0022490511],"about_ca_topic_score_codex":0.00042921503,"about_ca_topic_score_gemma":0.0008273244,"teacher_disagreement_score":0.19644025,"about_ca_system_score_codex":0.00036806148,"about_ca_system_score_gemma":0.00016128861,"threshold_uncertainty_score":0.99991965},"labels":[],"label_agreement":null},{"id":"W4321850279","doi":"10.1177/20420986221146418","title":"Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Communications Research Centre Canada","funders":"Spark Therapeutics; Hemophilia Federation of America; HEMA Biologics; National Hemophilia Foundation; BioMarin Pharmaceutical; CSL Behring; Novo Nordisk; Sanofi; Pfizer; Roche; Bayer; Genentech; Britannia Pharmaceuticals; Grifols; Octapharma","keywords":"Medicine; Pharmacovigilance; Pharmacology; Intensive care medicine; Adverse effect; Family medicine; Pediatrics","score_opus":0.13329660432494164,"score_gpt":0.4440379314710621,"score_spread":0.31074132714612046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006680261,0.99310046,0.0000208634,0.00066774467,0.0006777263,0.002479033,0.0003008875,0.00019677976,0.0018884719],"genre_scores_gemma":[0.0026357027,0.9953599,0.00005833241,0.00016060793,0.00024528577,0.0002682081,0.0007061612,0.00010257534,0.0004632388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633044,0.0013288951,0.0008215003,0.00042797613,0.00050611637,0.00058508053],"domain_scores_gemma":[0.99606323,0.0025855005,0.00028978038,0.00087437074,0.000055331642,0.0001317921],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00069602317,0.0005303049,0.0014704562,0.0001806851,0.00058007415,0.000032520948,0.00053675415,0.0002088234,0.0001408843],"category_scores_gemma":[0.00009627294,0.00032175137,0.0004443344,0.0011581536,0.00032694422,0.00019431111,0.0002693149,0.0025764368,0.00011765506],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017332035,0.00036976574,0.0007031142,0.0026812344,0.0004962494,0.000013522432,0.0011461718,0.0000025838563,0.0000019978165,0.000026878077,0.00007054906,0.9943146],"study_design_scores_gemma":[0.0012838887,0.00006503302,0.00044221358,0.009254519,0.0006555116,0.0000066133857,0.00114634,0.00002999956,0.0000021370624,0.0005032351,0.9863268,0.00028370135],"about_ca_topic_score_codex":0.00034008193,"about_ca_topic_score_gemma":0.000527847,"teacher_disagreement_score":0.9940309,"about_ca_system_score_codex":0.000548203,"about_ca_system_score_gemma":0.00029797247,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W4391294433","doi":"10.1177/20420986231224227","title":"Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Medicine; Pharmacovigilance; Odds ratio; Database; Internal medicine; Interquartile range; Adverse effect","score_opus":0.0573512260930896,"score_gpt":0.4510608166314385,"score_spread":0.39370959053834886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391294433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97367036,0.005999145,0.0004433961,0.0012733939,0.010054852,0.0026006151,0.00032565472,0.00027035346,0.005362212],"genre_scores_gemma":[0.9957277,0.0011178767,0.000027533963,0.0007046605,0.00070085126,0.00030065273,0.000024525976,0.00006072211,0.0013354555],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529076,0.00093074323,0.0017809786,0.0008562822,0.0004783479,0.0006628742],"domain_scores_gemma":[0.99737227,0.0008297675,0.0007602961,0.0006303604,0.00009367508,0.00031361086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014361049,0.00047320782,0.0006642548,0.00027838774,0.00034282618,0.000024667388,0.00073374854,0.00008050173,0.00050813693],"category_scores_gemma":[0.00007538713,0.0003834267,0.00030071655,0.0013326812,0.0001340318,0.0005206481,0.00026715617,0.001276991,0.0000951898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010198018,0.005282686,0.26843736,0.0023217003,0.0033403728,0.00271193,0.03991758,0.3354601,0.08493109,0.0038140519,0.0035503167,0.24003479],"study_design_scores_gemma":[0.011139276,0.00015125003,0.051701263,0.00458194,0.0033394177,0.00004017559,0.028787903,0.08167881,0.03574301,0.0007794082,0.7795711,0.0024864571],"about_ca_topic_score_codex":0.00052689406,"about_ca_topic_score_gemma":0.0013161578,"teacher_disagreement_score":0.77602077,"about_ca_system_score_codex":0.0008337512,"about_ca_system_score_gemma":0.00034591995,"threshold_uncertainty_score":0.9998618},"labels":[],"label_agreement":null},{"id":"W4391546075","doi":"10.1177/20420986241228119","title":"Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harmonization; Pharmacovigilance; Medicine; Guideline; Drug reaction; Latin Americans; Authorization; Business; Regulatory authority; Environmental health; Accounting; Political science; Pharmacology; Adverse effect; Public administration; Drug; Computer security; Computer science","score_opus":0.18672207394740206,"score_gpt":0.5018522761571692,"score_spread":0.3151302022097672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391546075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034930094,0.99260503,0.00057722465,0.000059382273,0.0017028229,0.0021451525,0.0010146648,0.0000861022,0.0017746785],"genre_scores_gemma":[0.0042963102,0.9936804,0.000094530296,0.0000989627,0.00014687676,0.00019887857,0.0011803564,0.00007567521,0.00022799951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99377453,0.0014887002,0.0030079028,0.0007699857,0.00048047357,0.00047841808],"domain_scores_gemma":[0.9964502,0.0006563686,0.0019743291,0.0005562048,0.0002021313,0.00016078414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002911654,0.00072625984,0.0021749632,0.0004286415,0.00018050993,0.0000115429175,0.0004514201,0.00043121722,0.00054966833],"category_scores_gemma":[0.000055296117,0.0005751978,0.0005315353,0.0012055136,0.000381712,0.0005853308,0.00013814274,0.0017828054,0.000011142692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008815581,0.00026062687,0.000019613453,0.10322737,0.00032973537,0.00014367545,0.0006576643,0.00009707645,0.000013744261,0.00037887416,0.00023938567,0.89454406],"study_design_scores_gemma":[0.00040661902,0.00003080823,0.000009070853,0.090854876,0.00297622,0.0003081173,0.00013169025,0.00012326626,0.00012149526,0.0007504235,0.9038404,0.0004469841],"about_ca_topic_score_codex":0.000012292305,"about_ca_topic_score_gemma":0.000011476887,"teacher_disagreement_score":0.90360105,"about_ca_system_score_codex":0.0003383986,"about_ca_system_score_gemma":0.00052276085,"threshold_uncertainty_score":0.99966997},"labels":[],"label_agreement":null},{"id":"W4405771294","doi":"10.1177/20420986241309882","title":"Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Polypharmacy; Medicine; Cohort; Population; Association (psychology); Pharmacoepidemiology; Gerontology; Family medicine; Environmental health; Internal medicine; Pharmacology; Medical prescription","score_opus":0.011895100423129832,"score_gpt":0.34206337905623807,"score_spread":0.3301682786331082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405771294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932562,0.0031336069,0.00028890645,0.0020874264,0.0001568411,0.00058544,0.00006564378,0.00001152104,0.00041440636],"genre_scores_gemma":[0.99850434,0.0009280722,0.00021991122,0.0001395563,0.000022112472,0.000013009434,0.00007151561,0.000012757843,0.00008873648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983575,0.00014334201,0.00070643343,0.00018194783,0.00045702388,0.0001537593],"domain_scores_gemma":[0.9984767,0.0009238588,0.00035240495,0.00012843999,0.000055485478,0.000063107174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005269021,0.00011313454,0.00040513545,0.0001709209,0.000016066697,0.0000027423525,0.00007809034,0.000058525107,0.000113479386],"category_scores_gemma":[0.00008943719,0.000097482196,0.000043756045,0.00053115207,0.000058143676,0.00018098358,0.000019861085,0.00023346875,4.203138e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025230768,0.00009810014,0.9556735,0.0006187187,0.00016312435,0.000002187795,0.0004630068,0.00006420573,0.00002602662,0.00021187027,0.0000042675138,0.042422667],"study_design_scores_gemma":[0.0016807326,0.000013850721,0.9934419,0.0006054173,0.0002954058,4.6474045e-7,0.00015093661,0.0011486682,0.00057082076,0.00018835413,0.0018146106,0.00008888571],"about_ca_topic_score_codex":0.24295779,"about_ca_topic_score_gemma":0.19218527,"teacher_disagreement_score":0.050772518,"about_ca_system_score_codex":0.0002613116,"about_ca_system_score_gemma":0.0004639704,"threshold_uncertainty_score":0.82255524},"labels":[],"label_agreement":null},{"id":"W4411452877","doi":"10.1177/20420986251347360","title":"Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Alberta Hospital Edmonton; Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Centre for Addiction and Mental Health; Queen's University; University of Toronto; Providence Health Care; Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Depression (economics); Observational study; Real world evidence; Cohort; Cohort study; Intensive care medicine; Psychiatry; Emergency medicine; Internal medicine","score_opus":0.06788609557223399,"score_gpt":0.4571484546264376,"score_spread":0.3892623590542036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411452877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938977,0.00045216733,0.00012857118,0.00019314702,0.00009578247,0.0045741405,0.00018808473,0.000027367922,0.0004430348],"genre_scores_gemma":[0.99360913,0.0011327849,0.0038630746,0.00008952931,0.00001484749,0.0005259681,0.0004338848,0.00002398116,0.00030677047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961898,0.0006754058,0.0016188541,0.00082610257,0.0003864268,0.00030342836],"domain_scores_gemma":[0.9962058,0.002051013,0.0004902023,0.0009868357,0.00014853461,0.0001175995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010987226,0.00034220438,0.0014426564,0.00078678044,0.00005073832,0.00000784547,0.00019391453,0.000086236156,0.000030139645],"category_scores_gemma":[0.00010331956,0.0002630228,0.00021142715,0.0015999246,0.00009336974,0.0004834513,0.000048064278,0.00014409586,3.047339e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018472979,0.024617767,0.87106574,0.00007514791,0.0017903335,0.000028721981,0.0016750596,0.001992937,0.00004724499,0.00006118492,5.262009e-7,0.08017238],"study_design_scores_gemma":[0.0201162,0.0039381655,0.967938,0.00024022057,0.0038096276,1.9015917e-7,0.0011278678,0.0018807069,0.0001736065,0.00020197699,0.00040768678,0.00016577121],"about_ca_topic_score_codex":0.00081153685,"about_ca_topic_score_gemma":0.07199092,"teacher_disagreement_score":0.09687226,"about_ca_system_score_codex":0.0009913042,"about_ca_system_score_gemma":0.00028943288,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W4411467706","doi":"10.1177/20420986251347354","title":"Beyond pain relief: the thrombosis threat of celecoxib","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Celecoxib; Thrombosis; Intensive care medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.0064727027006660455,"score_gpt":0.28880543467430386,"score_spread":0.28233273197363784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411467706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7099052,0.0939636,0.009477972,0.013400713,0.0025911066,0.0037906507,0.000023522822,0.00025621074,0.166591],"genre_scores_gemma":[0.99020594,0.006002568,0.00039235025,0.002420569,0.00007618623,0.00004921874,0.0000066194075,0.00002010124,0.0008264194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846923,0.00030120992,0.00045103324,0.00023798636,0.00024217516,0.00029837387],"domain_scores_gemma":[0.99821496,0.0010414595,0.000118952434,0.0005218529,0.000060830356,0.000041920688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016425292,0.00019218656,0.00045736626,0.00011497608,0.00009410308,0.000004531323,0.00021203382,0.00008030392,0.00009783574],"category_scores_gemma":[0.00011190881,0.000121415374,0.000117202435,0.00048711037,0.0002561776,0.00010196573,0.00004802141,0.0002979277,0.000009796766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021879515,0.00065187545,0.10340254,0.0014389834,0.00037654515,0.00002646212,0.004372605,0.00051569706,0.0064881872,0.076100536,0.0013496068,0.803089],"study_design_scores_gemma":[0.011492243,0.00078334234,0.2825474,0.0025568686,0.0006808151,0.00001727914,0.0036815675,0.0034733673,0.051984124,0.10505552,0.53677905,0.0009484033],"about_ca_topic_score_codex":0.000027082702,"about_ca_topic_score_gemma":0.000097246855,"teacher_disagreement_score":0.8021406,"about_ca_system_score_codex":0.00010007068,"about_ca_system_score_gemma":0.00012268011,"threshold_uncertainty_score":0.49511752},"labels":[],"label_agreement":null},{"id":"W4417348029","doi":"10.1177/20420986251405091","title":"Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"China Primary Health Care Foundation","keywords":"Pharmacovigilance; Adverse Event Reporting System; Vigilance (psychology); Food and drug administration; Adverse effect; Adverse drug event; Breast cancer; Drug reaction; Adverse drug reaction","score_opus":0.08656220519098266,"score_gpt":0.44564625855438,"score_spread":0.3590840533633973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417348029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511486,0.0017634907,0.00018445143,0.00058219844,0.0006414681,0.00074537273,0.00080331153,0.000061603074,0.00010323326],"genre_scores_gemma":[0.99717283,0.0019148086,0.000085464315,0.00035254215,0.000100209705,0.00008053313,0.0000836049,0.000022326578,0.00018767036],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99770015,0.00032252245,0.0008198512,0.00049478165,0.00023978254,0.0004228823],"domain_scores_gemma":[0.9980551,0.00056124706,0.0009645349,0.00021179447,0.000103557766,0.00010375581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007440351,0.0003344432,0.00038503553,0.000093634844,0.00072152226,0.00001277567,0.0001161565,0.00007140135,0.000010770427],"category_scores_gemma":[0.00007581296,0.00025467147,0.000042948246,0.00032648115,0.00014531435,0.00041678816,0.000059168233,0.00047975287,1.6873035e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009077903,0.0020354206,0.40307873,0.0017132194,0.0028942314,0.0004943446,0.0033641674,0.4247961,0.108041905,0.00051330484,0.000037718928,0.043952927],"study_design_scores_gemma":[0.025546173,0.00023864278,0.46533668,0.005293166,0.0037407414,0.0013300307,0.025136009,0.43959045,0.019912373,0.000045903904,0.012036922,0.001792903],"about_ca_topic_score_codex":0.013674713,"about_ca_topic_score_gemma":0.23211847,"teacher_disagreement_score":0.21844375,"about_ca_system_score_codex":0.001117076,"about_ca_system_score_gemma":0.0007838789,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W7117130945","doi":"10.1177/20420986251395925","title":"Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Adverse effect; Vaccination; Public health; Position paper; Orthostatic vital signs; Pandemic","score_opus":0.0357632173899468,"score_gpt":0.4485094486427596,"score_spread":0.4127462312528128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117130945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57858706,0.21805286,0.083184846,0.02490301,0.019999037,0.020196458,0.0013150632,0.0019547723,0.051806886],"genre_scores_gemma":[0.9752237,0.019304302,0.0006334201,0.002688469,0.00021083483,0.00043899583,0.00010548509,0.000037192585,0.0013575739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771565,0.0003407517,0.0006785829,0.0005055476,0.0001378641,0.0006215974],"domain_scores_gemma":[0.9988328,0.000496437,0.00019561978,0.0002671301,0.000094354604,0.000113616974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008648716,0.0003673414,0.0005284262,0.00018159054,0.0005199763,0.000008766735,0.00038435298,0.00016507554,0.000106259795],"category_scores_gemma":[0.000029932657,0.00035442298,0.00015455952,0.0005316251,0.00010565507,0.00069055427,0.00010783541,0.00066386943,0.00001415356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138441,0.002322169,0.06669168,0.0062174248,0.0029174306,0.0001576325,0.0039264904,0.049923062,0.27421853,0.128939,0.0016922752,0.4491502],"study_design_scores_gemma":[0.021087768,0.00012398903,0.0038922427,0.0008496368,0.0006576231,0.0000712001,0.0018000173,0.043576147,0.012274788,0.010899298,0.90374583,0.001021455],"about_ca_topic_score_codex":0.000019359395,"about_ca_topic_score_gemma":0.000095896,"teacher_disagreement_score":0.90205353,"about_ca_system_score_codex":0.0007713482,"about_ca_system_score_gemma":0.00036651964,"threshold_uncertainty_score":0.9998908},"labels":[],"label_agreement":null}]}